Background: With improved and readily accessible imaging techniques, the shift in fine-needle aspiration cytology (FNAC) from palpation-guided FNA (PGFNA) to image-guided FNA (IGFNA) and endoscopic ultrasound-guided FNA (EUS-FNA) became evident in last few decades. The present study evaluates the impact of IGFNA and EUS-FNA on the practice of cytopathology at our 300-bedded oncology institute. Study Design: A 10-year audit of three aspiration modalities PGFNA, IGFNA, and EUS-FNA was done. The number of aspirates, inadequacy rates, new patient registration numbers, and tissue biopsy numbers were compared. Results: A total of 29,610 FNAC were evaluated against a total 141,333 new patient registrations over a period of 10 years. The new cancer patient registration over last 10 years showed a 56% increase, with a comparable increase of 60% in diagnostic biopsies; whereas, the number of FNAC increased by only 6%. This reduction in the number of aspirates was mainly due to fall in the number of PGFNA to 18% of all procedures in the year of 2019 from a high of 44% in 2011. Further, PGFNA showed a reduction by 50% over 3 years. The inadequacy rates of PGFNA increased to 9.1% (in 2019) from 1.6% (in 2012). The IGFNA constituted 46%–60% of procedures, with inadequacy varying from 8.5% to 12.1% over years. The EUS-FNAC gradually increased from 3% to 22% from 2013, and the inadequacy rates were variable overtime showing parallelism with the use of rapid on-site adequacy evaluation (ROSE) by the endoscopist. Inadequacy rates ranged from 7.1% (2013) to 2.6% (2016), 7.7% (2017), and 5.4% (2019). Conclusion: The utility of ROSE and diminishing role of pathologist is highlighted in our study. Judicious ROSE improves diagnostic accuracy, decreases the rate of missed diagnosis and the repetition of procedures. The study sheds light on the ever-increasing lacuna in the training of pathologists for blind as well as in image-guided FNAC. Further, it enumerates the factors leading to the underutilization of ROSE, its undisputed advantages, operator variations in procedure, smear preparation, and screening.

1.
Jakowski
JD
,
DiNardo
LJ
.
Advances in head and neck fine-needle aspiration and ultrasound technique for the pathologist
.
Semin Diagn Pathol
.
2015
;
32
:
284
95
. .
2.
Gonzalez
MF
,
Akhtar
I
,
Manucha
V
.
Changing trends and practices in cytopathology
.
Acta Cytol
.
2017
;
61
:
91
5
. .
3.
Sauer
T
,
Doughty
RW
,
Orszagh
V
,
Gravdehaug
B
.
The cytopathologist in the hospital – based fnac clinic: US image guidance is our new tool to an even better FNAC Practice
.
Mathews J Cytol Histol
.
2018
;
2
(
1
):
7
.
4.
Kamel
HM
.
Trends and challenges in pathology practice: choices and necessities
.
Sultan Qaboos Univ Med J
.
2011
;
11
(
1
):
38
44
.
5.
Jhala
NC
,
Jhala
DN
,
Chhieng
DC
,
Eloubeidi
MA
,
Eltoum
IA
.
Endoscopic ultrasound-guided fine-needle aspiration: a cytopathologist’s perspective
.
Am J ClinPathol
.
2003
;
120
(
3
):
351
67
.
6.
Rana
A
,
Rana
SS
.
Endoscopic ultrasound-guided tissue acquisition: techniques and challenges
.
J Cytol
.
2019 Jan
;
36
(
1
):
1
7
. .
7.
Baek
HW
,
Park
MJ
,
Rhee
YY
,
Lee
KB
,
Kim
MA
,
Park
IA
.
Diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration cytology of pancreatic lesions
.
J Pathol Transl Med
.
2015
;
49
(
1
):
52
60
. .
8.
Lai
JH
,
Lin
HH
,
Lin
CC
.
Factors affecting cytological results of endoscopic ultrasound guided-fine needle aspiration during learning
.
Diagn Pathol
.
2020
;
15
(
1
):
17
. .
9.
Fischer
AH
,
Benedict
CC
,
Amrikachi
M
.
Five top stories in cytopathology
.
Arch Pathol Lab Med
.
2013
;
137
(
7
):
894
906
. .
10.
Giardino
A
,
Gupta
S
,
Olson
E
,
Sepulveda
K
,
Lenchik
L
,
Ivanidze
J
,
Role of imaging in the era of precision medicine
.
Acad Radiol
.
2017
;
24
(
5
):
639
49
.
11.
Chuo
CB
,
Corder
AP
.
Core biopsy versus fine needle aspiration cytology in a symptomatic breast clinic
.
Eur J Surg Oncol
.
2003
;
29
(
4
):
374
8
. .
12.
Tham
TM
,
Iyengar
KR
,
Taib
NA
,
Yip
CH
.
Fine needle aspiration biopsy, core needle biopsy or excision biopsy to diagnose breast cancer-which is the ideal method?
Asian Pac J Cancer Prev
.
2009
;
10
(
1
):
155
8
.
13.
Clarke
D
,
Sudhakaran
N
,
Gateley
CA
.
Replace fine needle aspiration cytology with automated core biopsy in the triple assessment of breast cancer
.
Ann R Coll Surg Engl
.
2001
;
83
:
110
2
.
14.
Poller
DN
,
Doyle
V
,
Trimboli
P
,
Bongiovanni
M
.
Rates of Thy 1‐non‐diagnostic thyroid fine needle aspiration using the UK Royal College of Pathologists Thy Terminology. A systematic review of the literature comparing patients who undergo rapid on‐site evaluation and those who do not
.
Cytopathology
.
2020
;
31
(
6
):
502
8
.
15.
Bellevicine
C
,
Vigliar
E
,
Malapelle
U
,
Pisapia
P
,
Conzo
G
,
Biondi
B
,
Cytopathologists can reliably perform ultrasound-guided thyroid fine needle aspiration: a 1-year audit on 3,715 consecutive cases
.
Cytopathology
.
2016
;
27
(
2
):
115
21
.
16.
Rong
L
,
Kida
M
,
Yamauchi
H
,
Okuwaki
K
,
Miyazawa
S
,
Iwai
T
,
Factors affecting the diagnostic accuracy of endoscopic ultrasonography‐guided fine‐needle aspiration (EUS‐FNA) for upper gastrointestinal submucosal or extraluminal solid mass lesions
.
Dig Endosc
.
2012
;
24
:
358
63
.
17.
Rana
D
,
Narine
N
.
An audit of the cytological diagnosis of endoscopic ultrasound-guided fine needle aspiration cytology of the pancreas
.
Am J Clin Pathol
.
2015
;
144
(
Suppl 2
):
A087
. .
18.
Mangla
G
,
Arora
VK
,
Singh
N
.
Clinical audit of ultrasound guided fine needle aspiration in a general cytopathology service
.
J Cytol
.
2015
;
32
(
1
):
6
11
. .
19.
Menkens
H
,
Gill
AJ
,
Toon
C
.
Audit of fine needle aspiration cytology reporting of thyroid nodules
.
Pathology
.
2015
;
47
:
S105
6
. .
20.
Joseph
L
,
Edwards
JM
,
Nicholson
CM
,
Pitt
MA
,
Howat
AJ
.
An audit of the accuracy of fine needle aspiration using a liquid-based cytology system in the setting of a rapid access breast clinic
.
Cytopathology
.
2001
;
13
:
343
9
. .
21.
Navina
S
,
McGrath
K
,
Chennat
J
,
Singh
V
,
Pal
T
,
Zeh
H
,
Adequacy assessment of endoscopic ultrasound-guided, fine-needle aspirations of pancreatic masses for theranostic studies: optimization of current practices is warranted
.
Arch Pathol Lab Med
.
2014
;
138
(
7
):
923
8
.
22.
Udaya
P
.
Immediate on-site interpretation of fine-needle aspiration smears: a cost and compensation analysis
.
J Bronchol
.
2002
;
9
(
1
):
72
.
23.
Shahidi
N
,
Ou
G
,
Telford
J
,
Enns
R
.
When trainees reach competency in performing ERCP: a systematic review
.
Gastrointest Endosc
.
2015
;
81
(
6
):
1337
42
. .
24.
Goyal
R
,
Garg
PK
,
Bhatia
A
,
Arora
VK
,
Singh
N
.
Clinical audit of repeat fine needle aspiration in a general cytopathology service
.
J Cytol
.
2014
;
31
:
1
6
. .
25.
Chang
KJ
,
Katz
KD
,
Durbin
TE
,
Erickson
RA
,
Butler
JA
,
Lin
F
,
Endoscopic ultrasound-guided fine-needle aspiration
.
Gastrointest Endosc
.
1994
;
40
:
694
9
.
26.
Erickson
RA
,
Sayage-Rabie
L
,
Beissner
RS
.
Factors predicting the number of EUS-guided fine-needle passes for diagnosis of pancreatic malignancies
.
Gastrointest Endosc
.
2000
;
51
:
184
90
. .
27.
Rollins
SD
.
Teaching FNA techniques and ultrasound guided FNA
.
Cancer Cytopathol
.
2019
;
127
:
7
8
. .
28.
Huang
M
,
Wei
S
.
Overview of molecular testing of cytology specimens
.
Acta Cytol
.
2020
;
64
:
136
46
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.